Home > Products > CD15 & CD64 > Recombinant Human Anti-CD15 x Anti-CD64 Bispecific Antibody (CrossMab)

Recombinant Human Anti-CD15 x Anti-CD64 Bispecific Antibody (CrossMab)  (CROSSAB-H207)

Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget neutrophils to tumor cells. It is designed for the research of Leukemia therapy.

Specifications

Targets
CD15 & CD64
Type
CrossMab
Species Reactivity
Human
Target 1
CD15
Host Animal 1
Human
Target 2
CD64
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Leukemia

Targets

Target 1
CD15
Gene ID
UniProt ID
Alternative Names
FUT4; fucosyltransferase 4; LeX; CD15; ELFT; FCT3A; FUTIV; SSEA-1; FUC-TIV; 3-FAL; 3-fucosyl-N-acetyllactosamine; stage-specific embryonic antigen-1; Lewis X; X-hapten
Target 2
CD64
Gene ID
UniProt ID
Alternative Names
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD15 x Anti-CD64 Bispecific Antibody (CrossMab) (CROSSAB-H207). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD15 & CD64"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: